z-logo
open-access-imgOpen Access
Peripheral Nerve Degeneration in the HIV-1 Transgenic Rat
Author(s) -
Frank Denaro,
Nandini V. L. Hayes,
Odell D. Jones,
M. Elizabeth McCready,
Harry Davis,
Brian J. Reid,
Richard L. Gallo,
Joseph Bryant
Publication year - 2001
Publication title -
the scientific world journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.453
H-Index - 93
eISSN - 2356-6140
pISSN - 1537-744X
DOI - 10.1100/tsw.2001.182
Subject(s) - degeneration (medical) , transgene , human immunodeficiency virus (hiv) , axonal degeneration , genetically modified mouse , peripheral nerve , peripheral , medicine , pathology , biology , virology , anatomy , biochemistry , gene
. Neurological abnormalities of the peripheral (PNS) and central nervous system continue to cause debilitating symptoms in AIDS patients despite advances in antiviral therapy (1). How HIV-1 mediates PNS damage is unknown. Our understanding is limited by the lack of model systems in which HIV/PNS pathology can be studied. Studies on the recently developed HIV-1 transgenic rat (HIV-1TgR) reveal that a subset of these animals displays severe neurological signs. These symptoms include complete or partial paralysis, difficulties in walking and sensitivity to touch. Progressive skeletal muscle mass loss with increasing severity of motor symptoms occurs over time. These clinical observations suggest that morphological changes to the nerve might be found. Peripheral nerve was examined in a group of HIV-1 TGRs which displayed neurologic symptoms. By characterizing the abnormalities in this model, it may be possible to develop theories on pathogenesis relevant to treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom